Diseases & Disorders
(G99)
IRS Verified
DX Registered
990 on File
LYMPHANGIOMATOSIS & GORHAMS DISEASE ALLIANCE INC
Financial strength (30%)
78/100
Reliability (20%)
50/100
Effectiveness (25%)
63/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$119K
Total Revenue
$153K
Total Expenses
$345K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
73.4%
Fundraising Efficiency
N/A
Operating Reserve
27.01x
Liability-to-Asset
2.6%
Revenue Diversification
95.6%
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
73.4% | 83.5% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
27.0 mo | 11.9 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.6% | 0.6% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.6% | 93.4% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-56.1% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-50.7% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-28.8% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $119K | $153K | $345K | 73.4% | — |
| 2024 | $271K | $311K | $379K | 77.9% | 0 |
| 2023 | $121K | $281K | $419K | 42.7% | — |
| 2022 | $322K | $320K | $579K | 38.1% | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.